A new study has revealed that Metixene, an antiparkinsonian drug, has shown remarkable potential as a novel treatment for metastatic breast cancer and brain metastases, providing hope for patients facing this devastating disease. The study was conducted…
in Health
Metixene identified as a promising candidate in the treatment of metastatic brain cancer
